TRI 6.90% 2.7¢ trivarx ltd

Push Through, page-8

  1. 2,203 Posts.
    lightbulb Created with Sketch. 201
    From the Australian article...
    "The $US20 billion ($26bn) pharmaceutical giant Otsuka has signed a 90-day deal to trial Medibio’s device in conjunction with its leading drug Abilify, which is used for bipolar, major depressive disorders and schizophrenia."
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.